EUVIMEDEUVIMED entdecken
Crossref

Phosphatidylcholine-Plasmalogen-Oleic Acid Reduces BACE1 Expression in Human SH-SY5Y Cells

Haruka Okabayashi, Miki Yasuda, Chinatsu Nii, Ryo Sugishita, Keijo Fukushima, Kouki Yuasa, Satoshi Kotoura, Hiromichi Fujino

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b23-00787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Haruka Okabayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima Universi…. Hauptthemen laut MEDLINE: Neuroblastoma, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmalogens are a family of glycerophospholipids containing one vinyl-ether bond at the sn-1 position in the glycerol backbone, and play important roles in cellular homeostasis including neural transmission. Therefore, reductions of plasmalogens have been associated with neurodegenerative disorders, such as Alzheimer's disease (AD). To evaluate the potential protective effects of plasmalogens against the pathology of AD, protein expression levels of key factors in amyloid precursor protein (APP) metabolic processes were examined using human neuroblastoma SH-SY5Y cells. Here, phosphatidylcholine-plasmalogen-oleic acid (PC-PLS-18) was shown to reduce protein expression levels of β-site APP cleaving enzyme 1 (BACE1), clusterin, and Tau, factors involved in the amyloid β-associated pathogenesis of AD. Thus, PC-PLS-18 may have preventive effects against AD by delaying the onset risk for a certain period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaAlzheimer DiseaseHumansAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesPlasmalogensAspartic Acid EndopeptidasesOleic AcidPhosphatidylcholinesAmyloid beta-Protein Precursor

Stichwörter der Autor:innen

Tauplasmalogenβ-site amyloid precursor protein cleaving enzyme 1

Substanzen

Amyloid beta-PeptidesAmyloid Precursor Protein SecretasesPlasmalogensAspartic Acid EndopeptidasesOleic AcidPhosphatidylcholinesAmyloid beta-Protein PrecursorBACE1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University.
  • Central Research Institute, Marudai Food Co., Ltd.

Zitieren

APA

Okabayashi, H., Yasuda, M., Nii, C., Sugishita, R., Fukushima, K., Yuasa, K., Kotoura, S., & Fujino, H. (2024). Phosphatidylcholine-Plasmalogen-Oleic Acid Reduces BACE1 Expression in Human SH-SY5Y Cells. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00787

Vancouver

Okabayashi H, Yasuda M, Nii C, Sugishita R, Fukushima K, Yuasa K, et al. Phosphatidylcholine-Plasmalogen-Oleic Acid Reduces BACE1 Expression in Human SH-SY5Y Cells. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00787

BibTeX
@article{Okabayashi2024,
  author = {Okabayashi, Haruka and Yasuda, Miki and Nii, Chinatsu and Sugishita, Ryo and Fukushima, Keijo and Yuasa, Kouki and Kotoura, Satoshi and Fujino, Hiromichi},
  title = {Phosphatidylcholine-Plasmalogen-Oleic Acid Reduces BACE1 Expression in Human SH-SY5Y Cells},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b23-00787}
}
Kostenlos starten →